Researchers Identified METTL14 Role in Spinal Recovery
A study revealed that the METTL14 protein regulates neuroinflammation and autophagy following spinal cord injury.
Updated on Sept. 21, 2026 in Stroke
Scientists have determined that the METTL14 protein plays a critical role in controlling microglial autophagy and neuroinflammation after spinal cord injuries. Increasing the levels of this protein has been shown to support neurological recovery in experimental models.
Why it matters
Persistent neuroinflammation frequently hinders tissue repair and functional recovery for patients after a spinal cord injury. By regulating this inflammatory response, researchers hope to unlock new pathways for effective spinal repair.
Integrated MeRIP-seq and transcriptomic analyses identified ATG13 as a direct target of METTL14. Observations confirmed that METTL14 knockdown impairs autophagy and increases proinflammatory cytokines, while overexpression suppresses these harmful responses.
The players
METTL14
This protein functions as a critical regulator of microglial autophagy and neuroinflammation within the central nervous system.
ATG13
This gene acts as a specific target modified by m6A that is essential for the autophagic processes regulated by METTL14.
The details
The study utilized viral overexpression of METTL14 to demonstrate improvements in neurological recovery in vivo. These findings indicate that epitranscriptomic regulation could serve as a viable therapeutic strategy for promoting tissue repair.
Timeline
Two weeks post-injury, global m6A and METTL14 levels were observed to increase in the injured spinal cord.
The Big Picture
This discovery shifts the trajectory of regenerative medicine by identifying a precise molecular target for controlling the inflammatory environment. It advances the existing research into spinal cord injury repair by mapping the previously complex relationship between epitranscriptomics and autophagy.
This research identifies a potential therapeutic target that could eventually lead to new clinical treatments for managing inflammation after trauma. While the findings are currently limited to experimental models, they offer a foundation for future medical interventions focused on spinal cord repair.
The takeaway
Targeting specific proteins like METTL14 may one day help clinicians manage the inflammatory damage caused by spinal injuries. Future studies will be essential to translate these biological insights into effective therapies for human patients.
Further reading
Learn more about the latest findings in neurological damage recovery by visiting the Stroke section.
More information
Read the full details of this study in the peer-reviewed research article.
Source note: This article includes information reported by Nature.
